U.S. Markets close in 3 hrs 50 mins

Here's Why Cannabis Stocks (ACB, CRON) Are Gaining Today

Ryan McQueeney
NeuroMetrix (NURO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Shares of several notable cannabis stocks, including Aurora Cannabis ACB and Cronos Group CRON, were up more than 10% through early afternoon trading hours Monday on the back of continued industry deal making.

Aurora Cannabis saw bullish momentum after one of its partners, Radient Technologies, received a license that will allow it to extract higher-quality CBD. Radient is Aurora’s extraction-technology partner. Aurora said that the company can deliver higher throughputs than is possible with current benchmarks.

“With the upcoming new regulations permitting additional form factors and Radient's recent receipt of its processor license, we are in a strong position to rapidly expand production of a broad portfolio of extract-based products, tying in well with the significant scale-up of our global cannabis and hemp operations,” said Aurora CEO Terry Booth in a press release.

Aurora shares were up roughly 11% to $8.22 by Monday afternoon. The stock has now rallied nearly 70% since December 21. Shares still have some room to run before retesting a 52-week high of $12.52 reached in early October, but ACB certainly seems to have regained its momentum.

Fellow cannabis stock CRON was moving even more rapidly on Monday. With no confirmed news from Cronos emerging so far today, the gains are likely a result of some combination of industry optimism, short squeezing, and continued interest from momentum investors.

Cronos shares were up more than 18% to $24.61 in afternoon trading. The stock has surged more than 108% in the past month alone, making it one of the market’s hottest stocks in any industry.

Realistically, this momentum dates back to early December, when tobacco giant Altria MO announced to it would take a 45% stake in Cronos for about $1.8 billion. Altria’s investment should help Cronos expand its production capacity and distribution footprint, catapulting the company up the ranks in terms of reach.

Other notable cannabis stocks in the green Monday include Canopy Growth CGC (+4%), Aphria APHA (+13%), and Tilray TLRY (+7%).

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Cronos Group Inc. (CRON) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research